Connection

Co-Authors

This is a "connection" page, showing publications co-authored by MARCOS ROBERTO ESTECIO and YUE LU.
Connection Strength

0.905
  1. Commercial ChIP-Seq Library Preparation Kits Performed Differently for Different Classes of Protein Targets. J Biomol Tech. 2022 10 15; 33(3).
    View in: PubMed
    Score: 0.216
  2. SINE retrotransposons cause epigenetic reprogramming of adjacent gene promoters. Mol Cancer Res. 2012 Oct; 10(10):1332-42.
    View in: PubMed
    Score: 0.107
  3. Cigarette smoke exposure accelerates AML progression in FLT3-ITD models. Blood Adv. 2023 11 14; 7(21):6624-6629.
    View in: PubMed
    Score: 0.058
  4. Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. Exp Hematol. 2022 11; 115:44-53.
    View in: PubMed
    Score: 0.054
  5. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nat Commun. 2021 01 29; 12(1):687.
    View in: PubMed
    Score: 0.048
  6. Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020 Oct 08; 11(1):5144.
    View in: PubMed
    Score: 0.047
  7. Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020 09 24; 11(1):4840.
    View in: PubMed
    Score: 0.047
  8. DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells. Nucleic Acids Res. 2019 01 10; 47(1):152-167.
    View in: PubMed
    Score: 0.042
  9. Epigenetic synergy between decitabine and platinum derivatives. Clin Epigenetics. 2015; 7:97.
    View in: PubMed
    Score: 0.033
  10. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ. Cancer Res. 2015 Sep 15; 75(18):3980-90.
    View in: PubMed
    Score: 0.033
  11. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia. Cancer Res. 2015 Jul 15; 75(14):2833-43.
    View in: PubMed
    Score: 0.032
  12. TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells. Nucleic Acids Res. 2014 Jun; 42(11):6956-71.
    View in: PubMed
    Score: 0.030
  13. Age-related epigenetic drift in the pathogenesis of MDS and AML. Genome Res. 2014 Apr; 24(4):580-91.
    View in: PubMed
    Score: 0.029
  14. Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition. Genome Biol. 2013 Dec 24; 14(12):R144.
    View in: PubMed
    Score: 0.029
  15. The epigenome of AML stem and progenitor cells. Epigenetics. 2013 Jan; 8(1):92-104.
    View in: PubMed
    Score: 0.027
  16. Conserved DNA methylation patterns in healthy blood cells and extensive changes in leukemia measured by a new quantitative technique. Epigenetics. 2012 Dec 01; 7(12):1368-78.
    View in: PubMed
    Score: 0.027
  17. Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One. 2011; 6(7):e22110.
    View in: PubMed
    Score: 0.025
  18. Analysis of epigenetic modifications by next generation sequencing. Annu Int Conf IEEE Eng Med Biol Soc. 2009; 2009:6730.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.